1. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. (June 2021) Authors: Avouac, Jérôme; Drumez, Elodie; Hachulla, Eric; Seror, Raphaèle; Georgin-Lavialle, Sophie; El Mahou, Soumaya; Pertuiset, Edouard; Pham, Thao; Marotte, Hubert; Servettaz, Amélie; Domont, Fanny; Chazerain, Pascal; Devaux, Mathilde; Claudepierre, Pascal; Langlois, Vincent; Mekinian, Arsène; Maria, A... Journal: Lancet Issue: Volume 3:Number 6(2021) Page Start: e419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Do JAK inhibitors affect immune response to COVID-19 vaccination? Data from the MAJIK-SFR Registry. (January 2022) Authors: Seror, Raphaèle; Camus, Marine; Salmon, Jean-Hugues; Roux, Christian; Dernis, Emmanuelle; Basch, André; Germain, Vincent; Leske, Charles; Brousseau, Steeve; Truchetet, Marie-Elise; Ramon, André; Gottenberg, Jacques-Eric; Felten, Renaud; Coury, Fabienne; Colombey, Antoine; Prati, Clément; Mariette... Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗